Advertisement

Index by author

February 01, 2001; Volume 296,Issue 2

  1. Abendschein, Dana R.

    1. A Novel Synthetic Inhibitor of Factor Xa Decreases Early Reocclusion and Improves 24-h Patency after Coronary Fibrinolysis in Dogs
      Dana R. Abendschein, Pamela K. Baum, Peter Verhallen, Paul R. Eisenberg, Mark E. Sullivan and David R. Light
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 567-572;

  2. Adams, J. L.

    1. SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia
      F. C. Barone, E. A. Irving, A. M. Ray, J. C. Lee, S. Kassis, S. Kumar, A. M. Badger, R. F. White, M. J. McVey, J. J. Legos, J. A. Erhardt, A. H. Nelson, E. H. Ohlstein, A. J. Hunter, K. Ward, B. R. Smith, J. L. Adams and A. A. Parsons
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 312-321;

  3. Agostino, Mary

    1. Bradykinin Modulation of Tumor Vasculature: I. Activation of B2 Receptors Increases Delivery of Chemotherapeutic Agents into Solid Peripheral Tumors, Enhancing Their Efficacy
      Dwaine F. Emerich, Pamela Snodgrass, Reginald L. Dean, Denise Lafreniere, Mary Agostino, Tania Wiens, Hua Xiong, Brant Hasler, Joanne Marsh, Melissa Pink, Byong Su Kim and Raymond T. Bartus
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 623-631;
    2. Bradykinin Modulation of Tumor Vasculature: II. Activation of Nitric Oxide and Phospholipase A2/Prostaglandin Signaling Pathways Synergistically Modifies Vascular Physiology and Morphology to Enhance Delivery of Chemotherapeutic Agents to Tumors
      Dwaine F. Emerich, Reginald L. Dean, Pamela Snodgrass, Denise Lafreniere, Mary Agostino, Tania Wiens, Hua Xiong, Brant Hasler, Joanne Marsh, Melissa Pink, Byong Su Kim, Brigido Perdomo and Raymond T. Bartus
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 632-641;

  4. Al-nakkash, Layla

    1. A Common Mechanism for Cystic Fibrosis Transmembrane Conductance Regulator Protein Activation by Genistein and Benzimidazolone Analogs
      Layla Al-Nakkash, Shenghui Hu, Min Li and Tzyh-Chang Hwang
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 464-472;

  5. Alakhov, Valery Yu

    1. Pluronic P85 Enhances the Delivery of Digoxin to the Brain: In Vitro and in Vivo Studies
      Elena V. Batrakova, Donald W. Miller, Shu Li, Valery Yu Alakhov, Alexander V. Kabanov and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 551-557;

  6. Andoh, Tsugunobu

    1. Gabapentin Antinociception in Mice with Acute Herpetic Pain Induced by Herpes Simplex Virus Infection
      Ichiro Takasaki, Tsugunobu Andoh, Hiroshi Nojima, Kimiyasu Shiraki and Yasushi Kuraishi
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 270-275;

  7. Aoki, Yasuaki

    1. Effective Plasma Concentration of a Novel Na+/Ca2+ Channel Blocker NS-7 for Its Cerebroprotective Actions in Rats with a Transient Middle Cerebral Artery Occlusion
      Yasuaki Aoki, Masaru Tamura, Yoshinori Itoh, Toshie Seto, Kiyoko Nonaka, Hideya Mukai and Yojiro Ukai
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 306-311;

  8. Ashby, John

    1. Assessment of the Effects of Metabolism on the Estrogenic Activity of Xenoestrogens: A Two-Stage Approach Coupling Human Liver Microsomes and a Yeast Estrogenicity Assay
      Robert Elsby, James L. Maggs, John Ashby, David Paton, John P. Sumpter and B. Kevin Park
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 329-337;

  9. Babal, Pavel

    1. Regulation of Ornithine Decarboxylase Activity and Polyamine Transport by Agmatine in Rat Pulmonary Artery Endothelial Cells
      Pavel Babál, Mykhaylo Ruchko, Clayton C. Campbell, Susan P. Gilmour, John L. Mitchell, Jack W. Olson and Mark N. Gillespie
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 372-377;

  10. Badger, A. M.

    1. SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia
      F. C. Barone, E. A. Irving, A. M. Ray, J. C. Lee, S. Kassis, S. Kumar, A. M. Badger, R. F. White, M. J. McVey, J. J. Legos, J. A. Erhardt, A. H. Nelson, E. H. Ohlstein, A. J. Hunter, K. Ward, B. R. Smith, J. L. Adams and A. A. Parsons
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 312-321;
« Previous (Pages : 1 2 3 4 5 6 ... 32) Next »
Back to top

In this issue

Advertisement